多肽定制Calcium Like Peptide 3 编码 [261969-05-5]

上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。

名称 Calcium Like Peptide 3
编码 [261969-05-5]
别名 Calcium Like Peptide 3
纯度 80%,90%,95%,98%,99%
重量 1mg,5mg,10mg,50mg,100mg,1g
序列(单字母缩写) VKFGVGFK
序列(三字母缩写) H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH (trifluoroacetate salt)
基本描述 An internally quenched peptide substrate for calpain-1 with optimal cleavage motifs flanking the scissile bond
溶解度
分子量 881.09
化学式 C44H68N10O9
存储条件 Store at -20°C. Keep tightly closed. Store in a cool dry place.
注释
Documents Calcium Like Peptide 3          编码     [261969-05-5]
Figures Calcium Like Peptide 3          编码     [261969-05-5]
Reference M.Villain et al., J. Biol. Chem., 275, 2676 (2000) M.K.Manion et al., FASEB J., 14, 1297 (2000) R.Ten Broeke et al., FASEB J., 15, 1831 (2001) R.Ten Broeke et al., Eur. J. Pharmacol., 476, 151 (2003)
C端
N端
化学桥

多肽定制Calcium/Calmodulin Dependent Protein Kinase II-g (345-358) 编码

上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。

名称 Calcium/Calmodulin Dependent Protein Kinase II-g (345-358)
编码
别名 Calcium/Calmodulin Dependent Protein Kinase II-g (345-358)
纯度 80%,90%,95%,98%,99%
重量 1mg,5mg,10mg,50mg,100mg,1g
序列(单字母缩写) KSDGGVKKRKSSSS
序列(三字母缩写) Lys-Ser-Asp-Gly-Gly-Val-Lys-Lys-Arg-Lys-Ser-Ser-Ser-Ser
基本描述
溶解度
分子量 1450.63
化学式 C58H107N21O22
存储条件 Store at -20°C. Keep tightly closed. Store in a cool dry place.
注释
Documents Calcium/Calmodulin Dependent Protein Kinase II-g (345-358)          编码
Figures Calcium/Calmodulin Dependent Protein Kinase II-g (345-358)          编码
Reference
C端
N端
化学桥

多肽定制Calcium-Like Peptide 编码 [145224-99-3]

上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。

名称 Calcium-Like Peptide
编码 [145224-99-3]
别名 Calcium-Like Peptide
纯度 80%,90%,95%,98%,99%
重量 1mg,5mg,10mg,50mg,100mg,1g
序列(单字母缩写) VAITVLVK
序列(三字母缩写) H-Val-Ala-Ile-Thr-Val-Leu-Val-Lys-OH (trifluoroacetate salt)
基本描述 The peptide acts as a calmodulin agonist, interacts with the calmodulin EF-hand motif, the Ca2+ binding site. CALP-3 activates the phosphodiesterase in the absence of Ca2+ and inhibits cytotoxicity and apoptosis in a Ca2+ mediated manner.
溶解度
分子量 842.09
化学式 C40H75N9O10
存储条件 Store at -20°C. Keep tightly closed. Store in a cool dry place.
注释
Documents Calcium-Like Peptide          编码     [145224-99-3]
Figures Calcium-Like Peptide          编码     [145224-99-3]
Reference .Dillon et al., Proc. Natl. Acad. Sci. USA, 88, 9726 (1991) M.K.Manion et al., FASEB J., 14, 1297 (2000) R.Houtman et al., J. Immunol., 166, 861 (2001) R.Ten Broeke et al., Eur. J. Pharmacol., 476, 151 (2003)
C端
N端
化学桥

Doxycycline calcium

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Doxycycline calcium 

Doxycycline calcium 是一种具有口服活性的四环素抗生素,是广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性和抗癌细胞增殖活性。

Doxycycline calcium

Doxycycline calcium Chemical Structure

CAS No. : 94088-85-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Doxycycline calcium 的其他形式现货产品:

Doxycycline Doxycycline (hyclate)

生物活性

Doxycycline calcium, an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]. Doxycycline calcium shows antibacterial activity and anti-cancer cell proliferation activity[1][2][3][4][5].

体外研究
(In Vitro)

Doxycycline calcium (0.01-10 µg/mL, 4 d) affects growth of glioma cells only under high concentrations[2].
Doxycycline calcium (0.01-10 µg/mL, 24 h) decreases MT-CO1 protein content with concentrations of 1 µg/mL and higher in SVG cells[2].
Doxycycline calcium (100 ng/mL, 1 µg/mL; 24 h) reduces proliferation of human cell lines[4].
Doxycycline calcium (0-250 μM, 72 h) inhibits cell viability of breast cancer cells [5].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: LNT-229, G55, and U343 glioma cells
Concentration: 0.01, 0.1, 1 or 10 µg/mL
Incubation Time: 4 days
Result: Affected growth of glioma cells only under high concentrations.

Cell Viability Assay[2]

Cell Line: SVG cells
Concentration: 0.01, 0.1, 1 or 10 µg/mL
Incubation Time: 24 hours
Result: Decreaseed MT-CO1 protein content with concentrations of 1 µg/mL and higher.

Cell Proliferation Assay[4]

Cell Line: MCF 12A, 293T cells
Concentration: 100 ng/mL, 1 µg/mL
Incubation Time: 96 hours
Result: Caused reduced proliferation of MCF 12A and 293T cells at 1 µg/mL.

Cell Viability Assay[5]

Cell Line: MCF-7, MDA-MB-468 cells
Concentration: 0-250 μM
Incubation Time: 72 hours
Result: Inhibited breast cancer cells in a dose-dependent manner with IC50 values for MCF-7 and MDA-MB-468 of 11.39 μM and 7.13 μM respectively.

体内研究
(In Vivo)

Doxycycline calcium (oral gavage; 200 or 800 mg/kg; once daily; 3 months) reduces MMP-9 activity in untreated HT mice in a dose-dependent manner[3].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6-month-old female Heterozygous Col3a1-deficient (HT) mice[3]
Dosage: 200 or 800 mg/kg
Administration: Oral gavage; 200 or 800 mg/kg; once daily; 3 months
Result: Reduced MMP-9 activity in a dose-dependent manner.

分子量

524.59

Formula

C22H24Ca2N2O8

CAS 号

94088-85-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Eusebio Manchado, et al. A combinatorial strategy for treating KRAS-mutant lung cancer. Nature. 2016 Jun 30;534(7609):647-51.

    [2]. Anna-Luisa Luger, et al. Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. Int J Mol Sci. 2018 May 17;19(5):1504.

    [3]. Wilfried Briest, et al. Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther. 2011 Jun;337(3):621-7.

    [4]. Ethan Ahler, et al. Doxycycline alters metabolism and proliferation of human cell lines. PLoS One. 2013 May 31;8(5):e64561.

    [5]. Le Zhang, et al. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle. 2017 Apr 18;16(8):737-745.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Levomefolate calcium(Synonyms: 左旋甲状腺素钙)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Levomefolate calcium (Synonyms: 左旋甲状腺素钙) 纯度: 97.11%

Levomefolate calcium 是叶酸的人造形式,抗叶酸的作用。

Levomefolate calcium(Synonyms: 左旋甲状腺素钙)

Levomefolate calcium Chemical Structure

CAS No. : 151533-22-1

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mg ¥450 In-stock
50 mg ¥650 In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

Levomefolate calcium 相关产品

相关化合物库:

  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • Bioactive Compound Library Plus
  • Cell Cycle/DNA Damage Compound Library
  • FDA-Approved Drug Library
  • Anti-Cancer Compound Library
  • Peptidomimetic Library
  • Anti-Aging Compound Library
  • Drug Repurposing Compound Library
  • Orally Active Compound Library
  • FDA Approved & Pharmacopeial Drug Library
  • Drug-Induced Liver Injury (DILI) Compound Library
  • Anti-Cancer Metabolism Compound Library
  • Rare Diseases Drug Library

生物活性

Levomefolate calcium is an artificial form of folate. IC50 Value: Target: Antifolate The calcium salt of L-5-methyltetrahydrofolic acid which belongs to the group of folate vitamins (Vitamin B9, Folacin). It is a coenzymated form of folic acid and a more bioavailable alternative in dietary supplements.

Clinical Trial

分子量

497.52

Formula

C20H23CaN7O6

CAS 号

151533-22-1

中文名称

左旋甲状腺素钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : 4.4 mg/mL (8.84 mM; Need ultrasonic and warming)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.0100 mL 10.0498 mL 20.0997 mL
5 mM 0.4020 mL 2.0100 mL 4.0199 mL
10 mM

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

参考文献
  • [1]. Fruzzetti F. Beyaz?: an oral contraceptive fortified with folate. Womens Health (Lond Engl). 2012 Jan;8(1):13-9.

    [2]. Wiesinger H, Eydeler U, Richard F, et al. Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. Clin Drug Investig. 2012 Oct 1;32(10):673-84.

    [3]. Hartmut Blodea, Christine Klippingb, Frank Richardc, et al. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception.2012, 85(2), :177-184

    [4]. Rapkin RB, Creinin MD. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium. Expert Opin Pharmacother. 2011 Oct;12(15):2403-10. doi: 10.1517/14656566.2011.610791.

    [5]. Levomefolic_acid

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Levomefolate-13C5 calcium (Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium 是一种 13C 标记的 Levomefolate (calcium)。Levomefolate calcium 是叶酸的人造形式,抗叶酸的作用。

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Levomefolate-13C5 calcium is the 13C-labeled Levomefolate (calcium). Levomefolate calcium is an artificial form of folate.

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

497.44

Formula

C1513C5H18CaN7O6

中文名称

左旋甲状腺素钙 13C5 (钙盐)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Fruzzetti F. Beyaz?: an oral contraceptive fortified with folate. Womens Health (Lond Engl). 2012 Jan;8(1):13-9.

    [3]. Wiesinger H, Eydeler U, Richard F, et al. Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. Clin Drug Investig. 2012 Oct 1;32(10):673-84.

    [4]. Hartmut Blodea, Christine Klippingb, Frank Richardc, et al. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception.2012, 85(2), :177-184

    [5]. Rapkin RB, Creinin MD. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium. Expert Opin Pharmacother. 2011 Oct;12(15):2403-10. doi: 10.1517/14656566.2011.610791.

    [6]. Levomefolic_acid

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Levomefolate-13C5 calcium (Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium 是一种 13C 标记的 Levomefolate (calcium)。Levomefolate calcium 是叶酸的人造形式,抗叶酸的作用。

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Levomefolate-13C5 calcium is the 13C-labeled Levomefolate (calcium). Levomefolate calcium is an artificial form of folate.

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

497.44

Formula

C1513C5H18CaN7O6

中文名称

左旋甲状腺素钙 13C5 (钙盐)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Fruzzetti F. Beyaz?: an oral contraceptive fortified with folate. Womens Health (Lond Engl). 2012 Jan;8(1):13-9.

    [3]. Wiesinger H, Eydeler U, Richard F, et al. Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. Clin Drug Investig. 2012 Oct 1;32(10):673-84.

    [4]. Hartmut Blodea, Christine Klippingb, Frank Richardc, et al. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception.2012, 85(2), :177-184

    [5]. Rapkin RB, Creinin MD. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium. Expert Opin Pharmacother. 2011 Oct;12(15):2403-10. doi: 10.1517/14656566.2011.610791.

    [6]. Levomefolic_acid

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Levomefolate-13C5 calcium (Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium 是一种 13C 标记的 Levomefolate (calcium)。Levomefolate calcium 是叶酸的人造形式,抗叶酸的作用。

Levomefolate-13C5 calcium(Synonyms: 5-Methyltetrahydrofolic Acid-13C5 calcium salt)

Levomefolate-13C5 calcium Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Levomefolate-13C5 calcium is the 13C-labeled Levomefolate (calcium). Levomefolate calcium is an artificial form of folate.

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

497.44

Formula

C1513C5H18CaN7O6

中文名称

左旋甲状腺素钙 13C5 (钙盐)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Fruzzetti F. Beyaz?: an oral contraceptive fortified with folate. Womens Health (Lond Engl). 2012 Jan;8(1):13-9.

    [3]. Wiesinger H, Eydeler U, Richard F, et al. Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone. Clin Drug Investig. 2012 Oct 1;32(10):673-84.

    [4]. Hartmut Blodea, Christine Klippingb, Frank Richardc, et al. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception.2012, 85(2), :177-184

    [5]. Rapkin RB, Creinin MD. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium. Expert Opin Pharmacother. 2011 Oct;12(15):2403-10. doi: 10.1517/14656566.2011.610791.

    [6]. Levomefolic_acid

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Calcium N5-methyltetrahydrofolate (Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate(NSC173328)是levomefolic acid的钙盐,可作用于心血管疾病和乳腺癌、结直肠癌。

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate Chemical Structure

CAS No. : 26560-38-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Calcium N5-methyltetrahydrofolate(NSC173328) is the calcium salt of levomefolic acid, which has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers. IC50 value: Target:

分子量

497.52

Formula

C20H23CaN7O6

CAS 号

26560-38-3

中文名称

N5-甲基四氢叶酸钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Levomefolic acid. From Wikipedia, the free encyclopedia

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Calcium N5-methyltetrahydrofolate (Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate(NSC173328)是levomefolic acid的钙盐,可作用于心血管疾病和乳腺癌、结直肠癌。

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate Chemical Structure

CAS No. : 26560-38-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Calcium N5-methyltetrahydrofolate(NSC173328) is the calcium salt of levomefolic acid, which has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers. IC50 value: Target:

分子量

497.52

Formula

C20H23CaN7O6

CAS 号

26560-38-3

中文名称

N5-甲基四氢叶酸钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Levomefolic acid. From Wikipedia, the free encyclopedia

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Calcium N5-methyltetrahydrofolate (Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate(NSC173328)是levomefolic acid的钙盐,可作用于心血管疾病和乳腺癌、结直肠癌。

Calcium N5-methyltetrahydrofolate(Synonyms: N5-甲基四氢叶酸钙; NSC173328)

Calcium N5-methyltetrahydrofolate Chemical Structure

CAS No. : 26560-38-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Calcium N5-methyltetrahydrofolate(NSC173328) is the calcium salt of levomefolic acid, which has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers. IC50 value: Target:

分子量

497.52

Formula

C20H23CaN7O6

CAS 号

26560-38-3

中文名称

N5-甲基四氢叶酸钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Levomefolic acid. From Wikipedia, the free encyclopedia

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Levoleucovorin Calcium(Synonyms: Calcium levofolinate; CL307782)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Levoleucovorin Calcium (Synonyms: Calcium levofolinate; CL307782) 纯度: 99.50%

Levoleucovorin Calcium 是folinic acid的活性形式。

Levoleucovorin Calcium(Synonyms: Calcium levofolinate;  CL307782)

Levoleucovorin Calcium Chemical Structure

CAS No. : 80433-71-2

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mM * 1 mL in Water ¥1045 In-stock
100 mg ¥950 In-stock
500 mg ¥2100 In-stock
1 g ¥3100 In-stock
2 g ¥4100 In-stock
5 g   询价  
10 g   询价  

* Please select Quantity before adding items.

Levoleucovorin Calcium 相关产品

相关化合物库:

  • Natural Product Library Plus
  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • FDA-Approved Drug Library Mini
  • Bioactive Compound Library Plus
  • Cell Cycle/DNA Damage Compound Library
  • Natural Product Library
  • FDA-Approved Drug Library
  • Anti-Cancer Compound Library
  • Anti-Aging Compound Library
  • Drug Repurposing Compound Library
  • Anti-COVID-19 Compound Library
  • FDA Approved & Pharmacopeial Drug Library
  • Alkaloids Library
  • Anti-Cancer Metabolism Compound Library
  • Children’s Drug Library

生物活性

Levoleucovorin calcium is the calcium salt of Levoleucovorin, which is the enantiomerically active form of folinic acid. IC50 value: Target: Levoleucovorin is used to treat or prevent toxic effects of methotrexate in people who have received methotrexate to treat bone cancer. Levoleucovorin is also used in combination chemotherapy with fluorouracil (5-FU) to treat colorectal cancer that has spread to other parts of the body. This medicine only treats the symptoms of colorectal cancer and does not treat the cancer itself.

Clinical Trial

分子量

511.50

Formula

C20H21CaN7O7

CAS 号

80433-71-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
In Vitro: 

H2O : 10 mg/mL (19.55 mM; Need ultrasonic)

DMSO : < 1 mg/mL (insoluble or slightly soluble)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9550 mL 9.7752 mL 19.5503 mL
5 mM 0.3910 mL 1.9550 mL 3.9101 mL
10 mM 0.1955 mL 0.9775 mL 1.9550 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

参考文献
  • [1]. Levomefolic acid. From Wikipedia, the free encyclopedia

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Folinic acid calcium salt pentahydrate(Synonyms: Leucovorin calcium salt pentahydrate)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Folinic acid calcium salt pentahydrate (Synonyms: Leucovorin calcium salt pentahydrate) 纯度: ≥98.0%

Folinic acid calcium salt pentahydrate (Leucovorin calcium salt pentahydrate) 是一种生物叶酸,通常与甲氨蝶呤 (MTX) 一起作为挽救剂服用,以降低 MTX 诱导的毒性。

Folinic acid calcium salt pentahydrate(Synonyms: Leucovorin calcium salt pentahydrate)

Folinic acid calcium salt pentahydrate Chemical Structure

CAS No. : 6035-45-6

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
100 mg ¥550 In-stock
500 mg ¥1800 In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Folinic acid calcium salt pentahydrate 相关产品

相关化合物库:

  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • Bioactive Compound Library Plus
  • Peptidomimetic Library

生物活性

Folinic acid calcium salt pentahydrate (Leucovorin calcium salt pentahydrate) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity[1].

体外研究
(In Vitro)

MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) [1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice)[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 24 Balb/c young growing male mice aged 3 weeks (11.88 ± 0.25 g)[2]
Dosage: 7.0 mg/kg
Administration: Intraperitoneal injection; every second day; for 3 weeks
Result: Following methotrexate (MTX) administration appears to reverse this growth inhibition.

Clinical Trial

分子量

601.58

Formula

C20H31CaN7O12

CAS 号

6035-45-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

溶解性数据
In Vitro: 

H2O : 10 mg/mL (16.62 mM; Need ultrasonic)

DMSO : < 1 mg/mL (insoluble or slightly soluble)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.6623 mL 8.3114 mL 16.6229 mL
5 mM 0.3325 mL 1.6623 mL 3.3246 mL
10 mM 0.1662 mL 0.8311 mL 1.6623 mL

*

请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用

参考文献
  • [1]. Keshava C, et al. Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. Mutat Res. 1998 Feb 2;397(2):221-8.

    [2]. Iqbal MP, et al. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr. 2003 Dec;92(12):1438-44.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Folinic acid calcium(Synonyms: 亚叶酸钙; Leucovorin calcium; Calcium folinate)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Folinic acid calcium (Synonyms: 亚叶酸钙; Leucovorin calcium; Calcium folinate) 纯度: 99.38%

Folinic acid calcium (Leucovorin calcium) 是一种生物叶酸,通常与甲氨蝶呤 (MTX) 一起作为挽救剂服用,以降低 MTX 诱导的毒性。

Folinic acid calcium(Synonyms: 亚叶酸钙; Leucovorin calcium;  Calcium folinate)

Folinic acid calcium Chemical Structure

CAS No. : 1492-18-8

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
100 mg ¥550 In-stock
500 mg ¥1500 In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Folinic acid calcium 相关产品

相关化合物库:

  • Natural Product Library Plus
  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • Bioactive Compound Library Plus

生物活性

Folinic acid calcium (Leucovorin calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity[1].

IC50 & Target

Human Endogenous Metabolite

 

体外研究
(In Vitro)

MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) [1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice)[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 24 Balb/c young growing male mice aged 3 weeks (11.88 ± 0.25 g)[2]
Dosage: 7.0 mg/kg
Administration: Intraperitoneal injection; every second day; for 3 weeks
Result: Following methotrexate (MTX) administration appears to reverse this growth inhibition.

Clinical Trial

分子量

511.50

Formula

C20H21CaN7O7

CAS 号

1492-18-8

中文名称

亚叶酸钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

溶解性数据
In Vitro: 

H2O : ≥ 200 mg/mL (391.01 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9550 mL 9.7752 mL 19.5503 mL
5 mM 0.3910 mL 1.9550 mL 3.9101 mL
10 mM 0.1955 mL 0.9775 mL 1.9550 mL

*

请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用

参考文献
  • [1]. Keshava C, et al. Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. Mutat Res. 1998 Feb 2;397(2):221-8.

    [2]. Iqbal MP, et al. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr. 2003 Dec;92(12):1438-44.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,

磷霉素钙

广谱抗生素
97%

有货

Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,

CAS编号 26016-98-8 | 品牌:Jinpan
Fosfomycin calcium

MSDS

质检证书(CoA)

相似产品

  • 分子式 C3H5O4PCa
  • 分子量176.12
  • MDL号 MFCD00070095
  • PubChem编号 93095

货号 (SKU) 包装规格 是否现货 价格 数量
P135734-1g 1g 现货 Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,  
P135734-5g 5g 现货 Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,  
P135734-10g 10g 现货 Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,  
P135734-25g 25g 现货 Cas(26016-98-8), Fosfomycin calcium, 磷霉素钙,Fosfomycin calcium,  

基本信息

产品名称 磷霉素钙
英文名称 Fosfomycin calcium
别名 磷霉素钙
英文别名 Phosphomycin calcium salt; phosphonomycin calcium salt;(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid
规格或纯度 97%
运输条件 常规运输
生化机理 Fosfomycin Calcium is the Ca2+ salt preparation of Fosfomycin, a phosphonic acid epoxide antibiotic. Fosfomycin is described to inhibit cell wall synthesis throμgh inhibition of UDP-N-acetylglucosamine enolpyruvyl transferase, the enzyme responsible for catalysis of the first committed step in peptidoglycan biosynthesis.Broad spectrum antibiotic. Inhibits UDP-N-acetylglucosamine enolpyruval transferase to inhibit bacterial wall synthesis. Orally active.

一般描述

A bacterial wall synthesis inhibitor

A bacterial wall synthesis inhibitor

相关属性

CAS编号 26016-98-8
MDL号 MFCD00070095
分子量 176.12
分子式 C3H5O4PCa
品牌 Jinpan
备注 如果有可能,您尽量在同一天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
PubChem CID 93095

Pitavastatin Calcium(Synonyms: 匹伐他汀钙; NK-104 hemicalcium; Pitavastatin hemicalcium)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Pitavastatin Calcium (Synonyms: 匹伐他汀钙; NK-104 hemicalcium; Pitavastatin hemicalcium) 纯度: 99.45%

Pitavastatin Calcium (NK-104 hemicalcium) 是有效的羟甲基戊二酰-CoA (HMG-CoA) 还原酶抑制剂。Pitavastatin Calcium 在 HepG2 细胞中抑制乙酸合成胆固醇的 IC50 为 5.8 nM。Pitavastatin Calcium 是一种高效的肝细胞低密度脂蛋白胆固醇 (LDL-C) 受体诱导剂。具有抗癌活性。

Pitavastatin Calcium(Synonyms: 匹伐他汀钙; NK-104 hemicalcium; Pitavastatin hemicalcium)

Pitavastatin Calcium Chemical Structure

CAS No. : 147526-32-7

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mM * 1 mL in DMSO ¥550 In-stock
10 mg ¥500 In-stock
50 mg ¥1200 In-stock
100 mg ¥2000 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Pitavastatin Calcium 相关产品

相关化合物库:

  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • FDA-Approved Drug Library Mini
  • Bioactive Compound Library Plus
  • Apoptosis Compound Library
  • Metabolism/Protease Compound Library
  • FDA-Approved Drug Library
  • Anti-Cancer Compound Library
  • Autophagy Compound Library
  • Anti-Aging Compound Library
  • Drug Repurposing Compound Library
  • Ferroptosis Compound Library
  • Anti-COVID-19 Compound Library
  • NMPA-Approved Drug Library
  • FDA Approved & Pharmacopeial Drug Library
  • Drug-Induced Liver Injury (DILI) Compound Library
  • Anti-Cancer Metabolism Compound Library
  • Mitochondria-Targeted Compound Library
  • Lipid Metabolism Compound Library
  • Rare Diseases Drug Library

生物活性

Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Anti-cancer activity[1][2][3].

体外研究
(In Vitro)

Pitavastatin Calcium inhibits the growth of a panel of ovarian cancer cells, including those considered most likely to represent HGSOC, grown as a monolayers (IC50 = 0.4-5 μM) or as spheroids (IC50=0.6-4 μM)[3].
Pitavastatin Calcium (1 μM; 48 hours ) induces apoptosis, evidenced by the increased activity of executioner caspases-3,7 as well as caspase-8 and caspase-9 in Ovcar-8 cells and Ovcar-3 cells[3].
Pitavastatin (1 μM, 48 hours) caused PARP cleavage in Ovcar-8 cells[3].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[3]

Cell Line: Ovcar-8 cells
Concentration: 1 μM
Incubation Time: 48 hours
Result: Induced PARP cleavage.

体内研究
(In Vivo)

Pitavastatin Calcium (59 mg/kg; p.o.; twice daily for 28 days) caused significant tumour regression[3].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 4 week old female NCR Nu/Nu female mice (bearing Ovcar-4 tumours)[3]
Dosage: 59 mg/kg
Administration: p.o.; twice daily for 28 days
Result: Caused significant tumour regression.

Clinical Trial

分子量

440.49

Formula

C25H23Ca0.5FNO4

CAS 号

147526-32-7

中文名称

匹伐他汀钙

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
In Vitro: 

DMSO : ≥ 50 mg/mL (113.51 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.2702 mL 11.3510 mL 22.7020 mL
5 mM 0.4540 mL 2.2702 mL 4.5404 mL
10 mM 0.2270 mL 1.1351 mL 2.2702 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (5.68 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.68 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (5.68 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.68 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (5.68 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (5.68 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献
  • [1]. Mukhtar RY, et al. Pitavastatin. Int J Clin Pract. 2005 Feb;59(2):239-52.

    [2]. Kajinami K, et al. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev. 2003 Fall;21(3):199-215.

    [3]. de Wolf E, et al.Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.Sci Rep. 2017 Jul 14;7(1):5410.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Ionomycin calcium(Synonyms: SQ23377 calcium)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Ionomycin calcium (Synonyms: SQ23377 calcium) 纯度: ≥98.0%

Ionomycin calcium (SQ23377 calcium) 是一种有效的,选择性的钙离子载体 (calcium ionophore),也是一种由 Streptomyces conglobatus 产生的抗生素。Ionomycin calcium (SQ23377 calcium) 对二价阳离子具有高度特异性 (Ca>Mg>Sr=Ba)。Ionomycin (SQ23377) 促进细胞凋亡。Ionomycin calcium (SQ23377 calcium) 还诱导蛋白激酶C (PKC) 激活。

Ionomycin calcium(Synonyms: SQ23377 calcium)

Ionomycin calcium Chemical Structure

CAS No. : 56092-82-1

规格 价格 是否有货 数量
1 mg ¥2380 In-stock
5 mg ¥5950 In-stock
10 mg ¥8400 In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Ionomycin calcium 相关产品

相关化合物库:

  • Covalent Screening Library Plus
  • Natural Product Library Plus
  • Bioactive Compound Library Plus
  • Anti-Infection Compound Library
  • Apoptosis Compound Library
  • Epigenetics Compound Library
  • Kinase Inhibitor Library
  • Membrane Transporter/Ion Channel Compound Library
  • Neuronal Signaling Compound Library
  • TGF-beta/Smad Compound Library
  • Natural Product Library
  • Anti-Cancer Compound Library
  • Covalent Screening Library
  • Oxygen Sensing Compound Library
  • Antibacterial Compound Library
  • Cytoskeleton Compound Library
  • Antibiotics Library
  • Exosomes Compound Library
  • Microbial Metabolite Library

生物活性

Ionomycin calcium (SQ23377 calcium) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin calcium (SQ23377 calcium) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin calcium (SQ23377 calcium) also induces the activation of protein kinase C (PKC)[1][2][3].

IC50 & Target

Calcium ionophore[1]

体外研究
(In Vitro)

Ionomycin is a Calcium ionophore and an antibiotic produced by Streptomyces conglobatus[1].
Addition of 2 μM Ionomycin to LCLC 103H cells causes an instantaneous increase in intracellular Ca2+ concentration from 50 to 180 nM. DNA and protein analysis in Ionomycin-treated cultures revealed DNA fragmentation and PARP cleavage to an 85-kDa fragment typical of caspase-mediated apoptosis. Necrosis could be detected in ~1-5% of the Ionomycin treated cells. Caspase activation in whole cells was followed by monitoring the increase in activity against Ac-DEVD-amc following Ionomycin treatment[2].
Ionomycin-mediated cleavage and exosome release. Following Ionomycin exposure, medium conditioned by SKOV3ip cells had increased amounts of exosomes containing the L1-32 cleavage fragment[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

分子量

747.07

Formula

C41H70CaO9

CAS 号

56092-82-1

中文名称

离子霉素钙盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : 50 mg/mL (66.93 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.3386 mL 6.6928 mL 13.3856 mL
5 mM 0.2677 mL 1.3386 mL 2.6771 mL
10 mM 0.1339 mL 0.6693 mL 1.3386 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (3.35 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (3.35 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (3.35 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (3.35 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献
  • [1]. Liu C,et al. Characterization of ionomycin as a calcium ionophore. J Biol Chem. 1978 Sep 10;253(17):5892-4.

    [2]. Chatila T, et al. Mechanisms of T cell activation by the calcium ionophore ionomycin. J Immunol. 1989 Aug 15;143(4):1283-9.

    [3]. Gil-Parrado S, et al. Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J Biol Chem. 2002 Jul 26;277(30):27217-26.

    [4]. Stoeck A, et al A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J. 2006 Feb 1;393(Pt 3):609-18.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务